TippingPoint Biosciences
San Francisco, US · Founded 2022 · 8 employees on LinkedIn · 2 known investors
TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer. Its approach aims to increase specificity, reduce toxicity, and limit drug resistance in oncology treatments.
Founders & leadership
TippingPoint Biosciences was founded in 2022 by Laura Hsieh.
LH
Laura HsiehinFounder & CEO
Investors · 2
Frequently asked questions
- What does TippingPoint Biosciences do?
- TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer. Its approach aims to increase specificity, reduce toxicity, and limit drug resistance in oncology treatments.
- Who founded TippingPoint Biosciences?
- TippingPoint Biosciences was founded by Laura Hsieh in 2022.
- Who are TippingPoint Biosciences's investors?
- TippingPoint Biosciences's investors include FREEFLOW, BrightEdge.
- Where is TippingPoint Biosciences headquartered?
- TippingPoint Biosciences is headquartered in San Francisco, US.